SODIUM TETRADECYL SULFATE

SODIUM TETRADECYL SULFATE was reported 55 times

SODIUM TETRADECYL SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TONGUE NECROSIS 2 0.0274
1 LYMPHATIC MALFORMATION 1 0.0263
2 VENOUS ANEURYSM 1 0.0217
3 INJECTION SITE ISCHAEMIA 1 0.0139
4 PHLEBOSCLEROSIS 1 0.0128
5 CHRONIC PIGMENTED PURPURA 2 0.0103
6 ATROPHY OF GLOBE 1 0.0078
7 SINOBRONCHITIS 1 0.0067
8 MUCOSAL NECROSIS 1 0.0064
9 AIR EMBOLISM 3 0.0064
10 POST PROCEDURAL PULMONARY EMBOLISM 1 0.0043
11 MUSCLE NECROSIS 2 0.0022
12 HYPHAEMA 1 0.0019
13 RENAL STONE REMOVAL 1 0.0018
14 DERMO-HYPODERMITIS 1 0.0017
15 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
16 PRODUCT CONFUSION 1 0.0013
17 EMBOLIA CUTIS MEDICAMENTOSA 1 0.0013
18 PSEUDOMONAL BACTERAEMIA 1 0.0012
19 VENOUS INJURY 1 0.0011
20 INJECTION SITE ULCER 1 0.0011
21 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
22 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
23 ACUTE LUNG INJURY 1 0.0008
24 IATROGENIC INJURY 1 0.0008
25 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
26 VASCULAR RUPTURE 1 0.0006
27 OPHTHALMOPLEGIA 1 0.0006
28 PORTAL VEIN THROMBOSIS 2 0.0006
29 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
30 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
31 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
32 CORNEAL OEDEMA 1 0.0004
33 KERATITIS 1 0.0003
34 EMBOLIC STROKE 1 0.0003
35 PERIPHERAL ISCHAEMIA 1 0.0002
36 FACIAL PARALYSIS 2 0.0002
37 PRODUCT COMMUNICATION ISSUE 2 0.0002
38 SKIN NECROSIS 1 0.0002
39 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
40 ISCHAEMIC STROKE 3 0.0002
41 ADVERSE REACTION 2 0.0002
42 PRODUCT LABEL ISSUE 1 0.0001
43 INFARCTION 1 0.0001
44 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
45 FURUNCLE 1 0.0001
46 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
47 ACUTE RESPIRATORY FAILURE 2 0.0001
48 EYELID PTOSIS 1 0.0001
49 ANKYLOSING SPONDYLITIS 1 0.0001
50 SINUS CONGESTION 1 0.0001
51 SKIN LESION 2 0.0001
52 PERIPHERAL COLDNESS 1 0.0001
53 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
54 ACUTE MYOCARDIAL INFARCTION 2 0.0001
55 MULTI-ORGAN FAILURE 1 0.0001
56 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
57 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
58 GASTRIC ULCER 1 0.0001
59 PULMONARY HYPERTENSION 1 0.0000
60 DEEP VEIN THROMBOSIS 3 0.0000
61 PRODUCT DISPENSING ERROR 1 0.0000
62 MUSCLE TWITCHING 1 0.0000
63 FIBROMYALGIA 1 0.0000
64 SKIN ULCER 1 0.0000
65 RESPIRATORY DISTRESS 1 0.0000
66 ANAPHYLACTIC REACTION 2 0.0000
67 DIVERTICULITIS 1 0.0000
68 WOUND 1 0.0000
69 DYSSTASIA 1 0.0000
70 INJECTION SITE RASH 1 0.0000
71 SWOLLEN TONGUE 1 0.0000
72 IMPAIRED HEALING 1 0.0000
73 OSTEONECROSIS 1 0.0000
74 STAPHYLOCOCCAL INFECTION 1 0.0000
75 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
76 DISEASE PROGRESSION 3 0.0000
77 BLINDNESS 1 0.0000
78 PULMONARY OEDEMA 1 0.0000
79 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
80 NEPHROLITHIASIS 1 0.0000
81 PULMONARY EMBOLISM 2 0.0000
82 RASH ERYTHEMATOUS 1 0.0000
83 LUNG DISORDER 1 0.0000
84 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
85 INFLAMMATION 1 0.0000
86 SEPSIS 2 0.0000
87 NASAL CONGESTION 1 0.0000
88 CATARACT 1 0.0000
89 FEBRILE NEUTROPENIA 1 0.0000
90 INJURY 1 0.0000
91 RESPIRATORY FAILURE 1 0.0000
92 THROMBOSIS 1 0.0000
93 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
94 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
95 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
96 EMOTIONAL DISTRESS 1 0.0000
97 OFF LABEL USE 7 0.0000
98 INFECTION 1 0.0000
99 HYPOAESTHESIA 1 0.0000
100 URTICARIA 1 0.0000
101 URINARY TRACT INFECTION 1 0.0000
102 MUSCLE SPASMS 1 0.0000
103 PAIN 3 0.0000
104 BACK PAIN 1 0.0000
105 COUGH 1 0.0000
106 INJECTION SITE PAIN 1 0.0000
107 ASTHENIA 1 0.0000
108 PRURITUS 1 0.0000
109 VOMITING 1 0.0000
110 HEADACHE 1 0.0000
111 DRUG INEFFECTIVE 2 0.0000
112 FATIGUE 1 0.0000
113 NAUSEA 1 0.0000